June 29, 2026
HTA Regulatory Interface Shapes Future Market Access
The HTA Regulatory Interface is emerging as a central factor in how European…
June 22, 2026
Pharma Market Access Challenges Shape European Competitiveness
Nathalie Moll, Director General of EFPIA, sets out why pharma market access now…
June 15, 2026
Portugal Access Delays Influence Reimbursement Strategies
Portugal access delays remain a defining challenge for health systems seeking to balance…
June 8, 2026
Incretin Economics: Strategic Lessons from New Obesity Therapies
The accelerating development of incretin-based therapies demands fresh thinking on incretin economics. Recent…
June 1, 2026
US Drug Pricing Trends and Global Comparisons
US drug pricing continues to shape debates on affordability and market access. Recent…
May 25, 2026
Barriers to Gene Therapy Access in Europe
Gene therapy access continues to challenge healthcare systems across Europe despite clear patient…